ETAO International Co., Ltd.
ETAO International Co., Ltd. (ETAO) Stock Overview
Explore ETAO International Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
9.8M
P/E Ratio
-0.01
EPS (TTM)
$-175.64
ROE
-13.69%
ETAO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ETAO International Co., Ltd. (ETAO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.10.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 9.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
ETAO International Co., Ltd., a digital healthcare company, provides medical care and biomedical technologies to patients in China. It is involved in designing an ecosystem that consist of hospitals, specialized clinics, artificial intelligence/big data diagnosis, medical analysis services, biotechnology companies, and an insurance agency company that enables patient to receive medical assistance and healthcare services. The company is based in New York, New York.
Wensheng Liu
3,600
1460 Broadway, New York City, NY
2021